Phase 1 clinical trials
In Dicot's first clinical trial, LIB-01 will be tested on healthy human candidates. The trial primarily aims to investigate the substance's safety profile in humans. At the same time, the appropriate dosage, drug uptake, metabolism and excretion will be studied. A Phase 1 trial usually takes approximately 1 year to complete until the final study report can be completed.